Plants and the central nervous system

被引:239
作者
Carlini, EA [1 ]
机构
[1] Univ Fed Sao Paulo, Paulista Sch Med, Dept Psychobiol, BR-04023062 Sao Paulo, Brazil
关键词
medicinal plants; plant adaptogens; khat; Ephedra spp; CNS plants; guarana; ayahuasca; iboga; Passiflora; Valeriana; Kava-kava; ST-JOHNS-WORT; GUARANA PAULLINIA-CUPANA; CATHA-EDULIS FORSK; HYPERICUM-PERFORATUM; BETA-CARBOLINES; BENZODIAZEPINE DEPENDENCE; DIFFERENTIAL INTERACTIONS; HUMAN PSYCHOPHARMACOLOGY; PSYCHOACTIVE COMPOUNDS; HALLUCINOGENIC PLANTS;
D O I
10.1016/S0091-3057(03)00112-6
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
This review article draws the attention to the many species of plants possessing activity on the central nervous system (CNS) In fact, they cover the whole spectrum of central activity such as psychoanaleptic, psycholeptic and psychodysleptic effects, and several of these plants are currently used in therapeutics to treat human ailments. Among the psychoanaleptic (stimulant) plants, those utilized by human beings to reduce body weight [Ephedra spp (Ma Huang), Paullinia spp (guarana), Catha edulis Forssk (khat)] and plants used to improve general health conditions (plant adaptogens) were scrutinized. Many species of hallucinogenic (psychodysleptic) plants are used by humans throughout the world to achieve states of mind distortions; among those, a few have been used for therapeutic purposes, such as Cannabis sativa L., Tabernanthe iboga Baill and the mixture of Psychotria viridis Ruiz and Pav and Banisteriopsis caapi (Spruce ex Griseb.) C.V Morton Plants showing central psycholeptic activities, such as analgesic or anxiolytic actions (Passiflora incarnata L., Valeriana spp and Piper methysticum G Forst.), were also analysed. Finally, the use of crude or semipurified extracts of such plants instead of the active substances seemingly responsible for their therapeutic effect is discussed. (C) 2003 Published by Elsevier Science Inc.
引用
收藏
页码:501 / 512
页数:12
相关论文
共 182 条
[1]   The psychopharmacology of hallucinogens [J].
Abraham, HD ;
Aldridge, AM ;
Gogia, P .
NEUROPSYCHOPHARMACOLOGY, 1996, 14 (04) :285-298
[2]  
ACETO MD, 1990, NIDA RES MG, V95, P578
[3]  
AIRAKSINEN MM, 1981, MED BIOL, V59, P190
[4]  
AIRAKSINEN MM, 1981, MED BIOL, V59, P21
[5]   Khat: Pharmacological and medical aspects and its social use in Yemen [J].
Al-Motarreb, A ;
Baker, K ;
Broadley, KJ .
PHYTOTHERAPY RESEARCH, 2002, 16 (05) :403-413
[6]   Plants with central analgesic activity [J].
Almeida, RN ;
Navarro, DS ;
Barbosa, JM .
PHYTOMEDICINE, 2001, 8 (04) :310-322
[7]   EFFECT OF VALEPOTRIATES ON THE BEHAVIOR OF RATS IN THE ELEVATED PLUS-MAZE DURING DIAZEPAM WITHDRAWAL [J].
ANDREATINI, R ;
LEITE, JR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 260 (2-3) :233-235
[8]  
[Anonymous], 1936, REV FLORA MED
[9]   The use of benzodiazepines in anxiety and other disorders [J].
Argyropoulos, SV ;
Nutt, DJ .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1999, 9 :407-412
[10]   CHARACTERIZATION OF THE DISCRIMINATIVE STIMULUS PROPERTIES INDUCED BY 5-HT1 AND 5-HT2 AGONISTS IN RATS [J].
ARNT, J .
PHARMACOLOGY & TOXICOLOGY, 1989, 64 (02) :165-172